Veraxa Biotech AG (VRXAW) Stock Analysis

What Veraxa Biotech AG does

Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]

Key metrics

ETFs linked to VRXAW

Broad-market and Healthcare sector ETFs an investor holding Veraxa Biotech AG is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how VRXAW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Veraxa Biotech AG?

Veraxa Biotech AG trades under the ticker VRXAW on NASDAQ.

Which exchange is VRXAW listed on?

VRXAW is listed on NASDAQ.

What sector does Veraxa Biotech AG operate in?

Veraxa Biotech AG is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VRXAW in a portfolio?

PortView shows VRXAW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.